{
  "id": "5c8c05c70101eac870000001",
  "type": "yesno",
  "question": "Is lactotransferrin a tumour suppressor?",
  "ideal_answer": "Lactotransferrin (LTF) has been confirmed to act as a tumor suppressor in multiple cancers.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/23069661",
    "http://www.ncbi.nlm.nih.gov/pubmed/25370482",
    "http://www.ncbi.nlm.nih.gov/pubmed/18697201",
    "http://www.ncbi.nlm.nih.gov/pubmed/23479198",
    "http://www.ncbi.nlm.nih.gov/pubmed/26137081"
  ],
  "snippets": [
    {
      "text": "LTF (lactotransferrin, or lactoferrin) plays important role in innate immunity, and its anti-tumor function has also been reported in multiple cancers.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23479198",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We previously reported that LTF is significantly down-regulated in nasopharyngeal carcinoma (NPC) and acts as a tumor suppressor by suppressing AKT signaling.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23479198",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The tumor suppressor function of lactotransferrin (LTF) has been reported in a variety of tumors, including GC, nasopharyngeal carcinoma (NPC) and prostate cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26137081",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Lactotransferrin (LTF) has been confirmed to act as a tumor suppressor in multiple cancers",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25370482",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23069661",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "LTF is likely to be a candidate tumor suppressor and downregulates the development of NPC by inhibiting NPC proliferation through induction of cell cycle arrest and modulation of the MAPK signaling pathway.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18697201",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}